TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling

Kumar H, Kawai T, Akira S (2011) Pathogen recognition by the innate immune system. Int Rev Immunol 30:16–34. https://doi.org/10.3109/08830185.2010.529976 Brubaker SW, Bonham KS, Zanoni I, Kagan JC (2015) Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol 33:257–290. https://doi.org/10.1146/annurev-immunol-032414-112240 Płóciennikowska A, Hromada-Judycka A, Borzęcka K, Kwiatkowska K (2015) Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 72:557–581. https://doi.org/10.1007/s00018-014-1762-5 Cao X (2016) Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat Rev Immunol 16:35–50. https://doi.org/10.1038/nri.2015.8 Fitzgerald KA, Kagan JC (2020) Toll-like receptors and the control of immunity. Cell 180:1044–1066. https://doi.org/10.1016/j.cell.2020.02.041 Poltorak A, Smirnova I, He X, Liu MY, Van Huffel C, McNally O, Birdwell D, Alejos E, Silva M, Du X, Thompson P, Chan EK, Ledesma J, Roe B, Clifton S, Vogel SN, Beutler B (1998) Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis 24:340–355 Yang H, Wang H, Ju Z, Ragab AA, Lundbäck P, Long W, Valdes-Ferrer SI, He M, Pribis JP, Li J, Lu B, Gero D, Szabo C, Antoine DJ, Harris HE, Golenbock DT, Meng J, Roth J, Chavan SS, Andersson U, Billiar TR, Tracey KJ, Al-Abed Y (2015) MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. J Exp Med 212:5–14. https://doi.org/10.1084/jem.20141318 Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medzhitov R, Noble PW (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11:1173–1179. https://doi.org/10.1038/nm1315 Manček-Keber M, Jerala R (2015) Postulates for validating TLR4 agonists. Eur J Immunol 45:356–370. https://doi.org/10.1002/eji.201444462 Kim HM, Kim Y-M (2018) HMGB1: LPS delivery vehicle for caspase-11-mediated pyroptosis. Immunity 49:582–584. https://doi.org/10.1016/j.immuni.2018.09.021 Miyake K, Nagai Y, Akashi S, Nagafuku M, Ogata M, Kosugi A (2002) Essential role of MD-2 in B-cell responses to lipopolysaccharide and Toll-like receptor 4 distribution. J Endotoxin Res 8:449–452. https://doi.org/10.1179/096805102125001055 Meng J, Gong M, Björkbacka H (1950) Golenbock DT (2011) Genome-wide expression profiling and mutagenesis studies reveal that lipopolysaccharide responsiveness appears to be absolutely dependent on TLR4 and MD-2 expression and is dependent upon intermolecular ionic interactions. J Immunol 187:3683–3693. https://doi.org/10.4049/jimmunol.1101397 Park BS, Song DH, Kim HM, Choi B-S, Lee H, Lee J-O (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458:1191–1195. https://doi.org/10.1038/nature07830 Park BS, Lee J-O (2013) Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med 45:e66–e66. https://doi.org/10.1038/emm.2013.97 Steimle A, Autenrieth IB, Frick J-S (2016) Structure and function: Lipid A modifications in commensals and pathogens. Int J Med Microbiol 306:290–301. https://doi.org/10.1016/j.ijmm.2016.03.001 Kelley SL, Lukk T, Nair SK (1950) Tapping RI (2013) The crystal structure of human soluble CD14 reveals a bent solenoid with a hydrophobic amino-terminal pocket. J Immunol 190:1304–1311. https://doi.org/10.4049/jimmunol.1202446 Tan Y, Zanoni I, Cullen TW, Goodman AL, Kagan JC (2015) Mechanisms of toll-like receptor 4 endocytosis reveal a common immune-evasion strategy used by pathogenic and commensal bacteria. Immunity 43:909–922. https://doi.org/10.1016/j.immuni.2015.10.008 Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470–1481. https://doi.org/10.2337/db07-1403 Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085–2088 Mayr FB, Yende S, Angus DC (2014) Epidemiology of severe sepsis Virulence 5:4–11. https://doi.org/10.4161/viru.27372 Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti J-F, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772. https://doi.org/10.2337/db06-1491 Velloso LA, Folli F, Saad MJ (2015) TLR4 at the crossroads of nutrients, gut microbiota, and metabolic inflammation. Endocr Rev 36:245–271. https://doi.org/10.1210/er.2014-1100 Molteni M, Gemma S, Rossetti C (2016) The role of Toll-Like receptor 4 in infectious and noninfectious inflammation. Mediators Inflamm. https://doi.org/10.1155/2016/6978936 Gambuzza M, Licata N, Palella E, Celi D, Foti Cuzzola V, Italiano D, Marino S, Bramanti P (2011) Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management. J Neuroimmunol 239:1–12. https://doi.org/10.1016/j.jneuroim.2011.08.010 Li Z, Block MS, Vierkant RA, Fogarty ZC, Winham SJ, Visscher DW, Kalli KR, Wang C, Goode EL (2016) The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins. Tumour Biol 37:13279–13286. https://doi.org/10.1007/s13277-016-5163-2 Deng M, Scott MJ, Loughran P, Gibson G, Sodhi C, Watkins S, Hackam D (1950) Billiar TR (2013) Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis. J Immunol 190:5152–5160. https://doi.org/10.4049/jimmunol.1300496 Zhang M, Zou L, Feng Y, Chen Y-J, Zhou Q, Ichinose F, Chao W (2014) Toll-like receptor 4 is essential to preserving cardiac function and survival in low-grade polymicrobial sepsis. Anesthesiology 121:1270–1280. https://doi.org/10.1097/ALN.0000000000000337 Vaure C, Liu Y (2014) A Comparative Review of Toll-Like Receptor 4 Expression and Functionality in Different Animal Species. Front Immunol. https://doi.org/10.3389/fimmu.2014.00316 Mahnke K, Becher E, Ricciardi-Castagnoli P, Luger TA, Schwarz T, Grabbe S (1997) CD14 is expressed by subsets of murine dendritic cells and upregulated by lipopolysaccharide. Adv Exp Med Biol 417:145–159. https://doi.org/10.1007/978-1-4757-9966-8_25 Sabroe I, Jones EC, Usher LR, Whyte MKB (1950) Dower SK (2002) Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 168:4701–4710. https://doi.org/10.4049/jimmunol.168.9.4701 Gangloff SC, Zähringer U, Blondin C, Guenounou M, Silver J (1950) Goyert SM (2005) Influence of CD14 on ligand interactions between lipopolysaccharide and its receptor complex. J Immunol 175:3940–3945 Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Huber M, Kalis C, Keck S, Galanos C, Freudenberg M, Beutler B (2005) CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6:565–570. https://doi.org/10.1038/ni1207 Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F, Kagan JC (2011) CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147:868–880. https://doi.org/10.1016/j.cell.2011.09.051 Borzęcka K, Płóciennikowska A, Björkelund H, Sobota A, Kwiatkowska K (2013) CD14 mediates binding of high doses of LPS but is dispensable for TNF-α production. Mediators Inflamm 2013:824919. https://doi.org/10.1155/2013/824919 Meissner F, Scheltema RA, Mollenkopf H-J, Mann M (2013) Direct proteomic quantification of the secretome of activated immune cells. Science 340:475–478. https://doi.org/10.1126/science.1232578 Björkbacka H, Fitzgerald KA, Huet F, Li X, Gregory JA, Lee MA, Ordija CM, Dowley NE, Golenbock DT, Freeman MW (2004) The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Physiol Genomics 19:319–330. https://doi.org/10.1152/physiolgenomics.00128.2004 Hirotani T, Yamamoto M, Kumagai Y, Uematsu S, Kawase I, Takeuchi O, Akira S (2005) Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta. Biochem Biophys Res Commun 328:383–392. https://doi.org/10.1016/j.bbrc.2004.12.184 Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640–643. https://doi.org/10.1126/science.1087262 Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, Hoshino K, Takeuchi O, Kobayashi M, Fujita T, Takeda K, Akira S (2002) Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420:324–329. https://doi.org/10.1038/nature01182 Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R (2008) TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9:361–368. https://doi.org/10.1038/ni1569 Husebye H, Halaas Ø, Stenmark H, Tunheim G, Sandanger Ø, Bogen B, Brech A, Latz E, Espevik T (2006) Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J 25:683–692. https://doi.org/10.1038/sj.emboj.7600991 Yu B, Wright SD (1996) Catalytic properties of lipopolysaccharide (LPS) binding protein transfer of LPS to soluble CD14. J Biol Chem 271:4100–4105. https://doi.org/10.1074/jbc.271.8.4100 Iovine N, Eastvold J, Elsbach P, Weiss JP, Gioannini TL (2002) The carboxyl-terminal domain of closely related endotoxin-binding proteins determines the target of protein-lipopolysaccharide complexes. J Biol Chem 277:7970–7978. https://doi.org/10.1074/jbc.M109622200 Gioannini TL, Teghanemt A, Zhang D, Levis EN, Weiss JP (2005) Monomeric endotoxin:protein complexes are essential for TLR4-dependent cell activation. J Endotoxin Res 11:117–123. https://doi.org/10.1179/096805105X35198 Tsukamoto H, Takeuchi S, Kubota K, Kobayashi Y, Kozakai S, Ukai I, Shichiku A, Okubo M, Numasaki M, Kanemitsu Y, Matsumoto Y, Nochi T, Watanabe K, Aso H, Tomioka Y (2018) Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKϵ-IRF3 axis activation. J Biol Chem 293:10186–10201. https://doi.org/10.1074/jbc.M117.796631 Ryu J-K, Kim SJ, Rah S-H, Kang JI, Jung HE, Lee D, Lee HK, Lee J-O, Park BS, Yoon T-Y, Kim HM (2017) Reconstruction of LPS transfer cascade reveals structural determinants within LBP, CD14, and TLR4-MD2 for efficient LPS recognition and transfer. Immunity 46:38–50. https://doi.org/10.1016/j.immuni.2016.11.007 Funda DP, Tucková L, Farré MA, Iwase T, Moro I, Tlaskalová-Hogenová H (2001) CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited. Infect Immun 69:3772–3781. https://doi.org/10.1128/IAI.69.6.3772-3781.2001 de Buhr MF, Hedrich H-J, Westendorf AM, Obermeier F, Hofmann C, Zschemisch N-H, Buer J, Bumann D, Goyert SM, Bleich A (2009) Analysis of Cd14 as a genetic modifier of experimental inflammatory bowel disease (IBD) in mice. Inflamm Bowel Dis 15:1824–1836. https://doi.org/10.1002/ibd.21030 Fernández-Real JM, Pérez del Pulgar S, Luche E, Moreno-Navarrete JM, Waget A, Serino M, Sorianello E, Sánchez-Pla A, Pontaque FC, Vendrell J, Chacón MR, Ricart W, Burcelin R, Zorzano A (2011) CD14 Modulates Inflammation-Driven Insulin Resistance. Diabetes 60:2179–2186. https://doi.org/10.2337/db10-1210 Roy S, Karmakar M, Pearlman E (2014) CD14 mediates Toll-like receptor 4 (TLR4) endocytosis and spleen tyrosine kinase (Syk) and interferon regulatory transcription factor 3 (IRF3) activation in epithelial cells and impairs neutrophil infiltration and Pseudomonas aeruginosa killing in vivo. J Biol Chem 289:1174–1182. https://doi.org/10.1074/jbc.M113.523167 Wu Z, Zhang Z, Lei Z, Lei P (2019) CD14: Biology and role in the pathogenesis of disease. Cytokine Growth Factor Rev 48:24–31. https://doi.org/10.1016/j.cytogfr.2019.06.003 Bufler P, Stiegler G, Schuchmann M, Hess S, Krüger C, Stelter F, Eckerskorn C, Schütt C, Engelmann H (1995) Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. Eur J Immunol 25:604–610. https://doi.org/10.1002/eji.1830250244 Delgado M, Leceta J, Abad C, Martinez C, Ganea D, Gomariz RP (1999) Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide. J Neuroimmunol 99:61–71. https://doi.org/10.1016/s0165-5728(99)00105-8 Arai Y, Mizugishi K, Nonomura K, Naitoh K, Takaori-Kondo A, Yamashita K (2015) Phagocytosis by human monocytes is required for the secretion of presepsin. J Infect Chemother 21:564–569. https://doi.org/10.1016/j.jiac.2015.04.011 Duchow J, Marchant A, Crusiaux A, Husson C, Alonso-Vega C, De Groote D, Neve P, Goldman M (1993) Impaired phagocyte responses to lipopolysaccharide in paroxysmal nocturnal hemoglobinuria. Infect Immun 61:4280–4285 Landmann R, Reber AM, Sansano S, Zimmerli W (1996) Function of soluble CD14 in serum from patients with septic shock. J Infect Dis 173:661–668. https://doi.org/10.1093/infdis/173.3.661 da Silva CJ, Soldau K, Christen U, Tobias PS, Ulevitch RJ (2001) Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J Biol Chem 276:21129–21135. https://doi.org/10.1074/jbc.M009164200 Kim J-I, Lee CJ, Jin MS, Lee C-H, Paik S-G, Lee H, Lee J-O (2005) Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J Biol Chem 280:11347–11351. https://doi.org/10.1074/jbc.M414607200 Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI (2002) Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 3:354–359. https://doi.org/10.1038/ni777 Sprong T, van der Ley P, Abdollahi-Roodsaz S, Joosten L, van der Meer J, Netea M, van Deuren M (2011) Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production. Innate Immun 17:517–525. https://doi.org/10.1177/1753425910383999 Hajjar AM, Ernst RK, Fortuno ES, Brasfield AS, Yam CS, Newlon LA, Kollmann TR, Miller SI, Wilson CB (2012) Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica. PLoS Pathog 8:e1002963. https://doi.org/10.1371/journal.ppat.1002963 Ohto U, Fukase K, Miyake K, Shimizu T (2012) Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc Natl Acad Sci U S A 109:7421–7426. https://doi.org/10.1073/pnas.1201193109 Meng J, Lien E, Golenbock DT (2010) MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation. J Biol Chem 285:8695–8702. https://doi.org/10.1074/jbc.M109.075127 Zhang Y, Gaekwad J, Wolfert MA, Boons G-J (2007) Modulation of innate immune responses with synthetic lipid A derivatives. J Am Chem Soc 129:5200–5216. https://doi.org/10.1021/ja068922a Pizzuto M, Lonez C, Baroja-Mazo A, Martínez-Banaclocha H, Tourlomousis P, Gangloff M, Pelegrin P, Ruysschaert J-M, Gay NJ, Bryant CE (2019) Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4. Cell Mol Life Sci 76:3667–3678. https://doi.org/10.1007/s00018-019-03113-5 Anwar MA, Panneerselvam S, Shah M, Choi S (2015) Insights into the species-specific TLR4 signaling mechanism in response to Rhodobacter sphaeroides lipid A detection. Sci Rep 5:7657. https://doi.org/10.1038/srep07657 Mullarkey M, Rose JR, Bristol J, Kawata T, Kimura A, Kobayashi S, Przetak M, Chow J, Gusovsky F, Christ WJ, Rossignol DP (2003) Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J Pharmacol Exp Ther 304:1093–1102. https://doi.org/10.1124/jpet.102.044487 Kim HM, Park BS, Kim J-I, Kim SE, Lee J, Oh SC, Enkhbayar P, Matsushima N, Lee H, Yoo OJ, Lee J-O (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130:906–917. https://doi.org/10.1016/j.cell.2007.08.002 Panter G, Jerala R (2011) The ectodomain of the Toll-like receptor 4 prevents constitutive receptor activation. J Biol Chem 286:23334–23344. https://doi.org/10.1074/jbc.M110.205419 Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O’Neill LA (2001) Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413:78–83. https://doi.org/10.1038/35092578 Horng T, Barton GM, Flavell RA, Medzhitov R (2002) The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420:329–333. https://doi.org/10.1038/nature01180 Bonham KS, Orzalli MH, Hayashi K, Wolf AI, Glanemann C, Weninger W, Iwasaki A, Knipe DM, Kagan JC (2014) A promiscuous lipid-binding protein diversifies the subcellular sites of toll-like receptor signal transduction. Cell 156:705–716. https://doi.org/10.1016/j.cell.2014.01.019 Kagan JC, Medzhitov R (2006) Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125:943–955. https://doi.org/10.1016/j.cell.2006.03.047 Aksoy E, Taboubi S, Torres D, Delbauve S, Hachani A, Whitehead MA, Pearce WP, Berenjeno IM, Nock G, Filloux A, Beyaert R, Flamand V, Vanhaesebroeck B (2012) The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock. Nat Immunol 13:1045–1054. https://doi.org/10.1038/ni.2426 Motshwene PG, Moncrieffe MC, Grossmann JG, Kao C, Ayaluru M, Sandercock AM, Robinson CV, Latz E, Gay NJ (2009) An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem 284:25404–25411. https://doi.org/10.1074/jbc.M109.022392 Lin S-C, Lo Y-C, Wu H (2010) Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465:885–890. https://doi.org/10.1038/nature09121 Lu Y-C, Yeh W-C, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine 42:145–151. https://doi.org/10.1016/j.cyto.2008.01.006 Laird MHW, Rhee SH, Perkins DJ, Medvedev AE, Piao W, Fenton MJ, Vogel SN (2009) TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J Leukoc Biol 85:966–977. https://doi.org/10.1189/jlb.1208763 Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637–650. https://doi.org/10.1016/j.immuni.2011.05.006 Kawai T, Takeuchi O, Fujita T, Inoue J, Mühlradt PF, Sato S, Hoshino K (1950) Akira S (2001) Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167:5887–5894. https://doi.org/10.4049/jimmunol.167.10.5887 Odendall C, Voak AA (1950) Kagan JC (2017) Type III interferons are commonly induced by bacteria-sensing TLRs, and reinforce epithelial barriers during infection. J Immunol 199:3270–3279. https://doi.org/10.4049/jimmunol.1700250 Chanteux H, Guisset AC, Pilette C, Sibille Y (2007) LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms. Respir Res 8:71. https://doi.org/10.1186/1465-9921-8-71 Troutman TD, Hu W, Fulenchek S, Yamazaki T, Kurosaki T, Bazan JF, Pasare C (2012) Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt. Proc Natl Acad Sci 109:273–278. https://doi.org/10.1073/pnas.1118579109 Ni M, MacFarlane AW, Toft M, Lowell CA, Campbell KS, Hamerman JA (2012) B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K. Proc Natl Acad Sci 109:267–272. https://doi.org/10.1073/pnas.1111957108 Borzęcka-Solarz K, Dembińska J, Hromada-Judycka A, Traczyk G, Ciesielska A, Ziemlińska E, Świątkowska A, Kwiatkowska K (2017) Association of Lyn kinase with membrane rafts determines its negative influence on LPS-induced signaling. Mol Biol Cell 28:1147–1159. https://doi.org/10.1091/mbc.E16-09-0632 Perkins DJ, Richard K, Hansen A-M, Lai W, Nallar S, Koller B, Vogel SN (2018) Autocrine-paracrine prostaglandin E2 signaling restricts TLR4 internalization and TRIF signaling. Nat Immunol 19:1309–1318. https://doi.org/10.1038/s41590-018-0243-7 Everts B, Amiel E, Huang SC-C, Smith AM, Chang C-H, Lam WY, Redmann V, Freitas TC, Blagih J, van der Windt GJW, Artyomov MN, Jones RG, Pearce EL, Pearce EJ (2014) TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation. Nat Immunol 15:323–332. https://doi.org/10.1038/ni.2833 Tan Y, Kagan JC (2019) Innate Immune signaling organelles display natural and programmable signaling flexibility. Cell 177:384–398.e11. https://doi.org/10.1016/j.cell.2019.01.039 Langston PK, Nambu A, Jung J, Shibata M, Aksoylar HI, Lei J, Xu P, Doan MT, Jiang H, MacArthur MR, Gao X, Kong Y, Chouchani ET, Locasale JW, Snyder NW, Horng T (2019) Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses. Nat Immunol 20:1186–1195. https://doi.org/10.1038/s41590-019-0453-7 Marongiu L, Gornati L, Artuso I, Zanoni I, Granucci F (2019) Below the surface: The inner lives of TLR4 and TLR9. J Leukoc Biol 106:147–160. https://doi.org/10.1002/JLB.3MIR1218-483RR Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T (2003) TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem 278:49751–49762. https://doi.org/10.1074/jbc.M305820200 Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, Golenbock DT, Espevik T (2002) Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 277:47834–47843. https://doi.org/10.1074/jbc.M207873200 Rowe DC, McGettrick AF, Latz E, Monks BG, Gay NJ, Yamamoto M, Akira S, O’Neill LA, Fitzgerald KA, Golenbock DT (2006) The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc Natl Acad Sci U S A 103:6299–6304. https://doi.org/10.1073/pnas.0510041103 Tanimura N, Saitoh S, Matsumoto F, Akashi-Takamura S, Miyake K (2008) Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem Biophys Res Commun 368:94–99. https://doi.org/10.1016/j.bbrc.2008.01.061 Husebye H, Aune MH, Stenvik J, Samstad E, Skjeldal F, Halaas O, Nilsen NJ, Stenmark H, Latz E, Lien E, Mollnes TE, Bakke O, Espevik T (2010) The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 33:583–596. https://doi.org/10.1016/j.immuni.2010.09.010 Liu S, Cai X, Wu J , Cong Q, Chen X, Li T, Du F, Ren J, Wu YT, Grishin NV, Chen ZJ (2015) Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation | Science. https://science.sciencemag.org/content/347/6227/aaa2630 Häcker H, Redecke V, Blagoev B, Kratchmarova I, Hsu L-C, Wang GG, Kamps MP, Raz E, Wagner H, Häcker G, Mann M, Karin M (2006) Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204–207. https://doi.org/10.1038/nature04369 Chang EY, Guo B, Doyle SE, Cheng G (2007) Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J Immunol 178:6705–6709. https://doi.org/10.4049/jimmunol.178.11.6705 Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K, Akira S (2003) Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol 171:4304–4310. https://doi.org/10.4049/jimmunol.171.8.4304 Cusson-Hermance N, Khurana S, Lee TH, Fitzgerald KA, Kelliher MA (2005) Rip1 mediates the Trif-dependent Toll-like receptor 3- and 4-induced NF-κB activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 280:36560–36566. https://doi.org/10.1074/jbc.M506831200 Kaiser WJ (1950) Offermann MK (2005) Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol 174:4942–4952. https://doi.org/10.4049/jimmunol.174.8.4942 He S, Liang Y, Shao F, Wang X (2011) Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci 108:20054–20059. https://doi.org/10.1073/pnas.1116302108 Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, Sehon CA, Marquis RW, Bertin J, Mocarski ES (2013) Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem 288:31268–31279. https://doi.org/10.1074/jbc.M113.462341 Najjar M, Saleh D, Zelic M, Nogusa S, Shah S, Tai A, Finger JN, Polykratis A, Gough PJ, Bertin J, Whalen MJ, Pasparakis M, Balachandran S, Kelliher M, Poltorak A, Degterev A (2016) RIPK1 and RIPK3 kinases promote cell-death-independent inflammation by Toll-like receptor 4. Immunity 45:46–59. https://doi.org/10.1016/j.immuni.2016.06.007 Yi Y-S (2017) Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses. Immunology 152:207–217. https://doi.org/10.1111/imm.12787 Barker JH, Weiss JP (2019) Detecting lipopolysaccharide in the cytosol of mammalian cells: Lessons from MD-2/TLR4. J Leukoc Biol 106:127–132. https://doi.org/10.1002/JLB.3MIR1118-434R Kelley N, Jeltema D, Duan Y, He Y (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. https://doi.org/10.3390/ijms20133328 Swanson KV, Deng M, Ting JP-Y (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19:477–489. https://doi.org/10.1038/s41577-019-0165-0 Evavold CL, Ruan J, Tan Y, Xia S, Wu H, Kagan JC (2018) The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity 48:35–44.e6. https://doi.org/10.1016/j.immuni.2017.11.013 Franchi L, Eigenbrod T (1950) Núñez G (2009) Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 183:792–796. https://doi.org/10.4049/jimmunol.0900173 Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald K, Hornung V, Latz E (2009) Cutting Edge: NF-κB activating pattern recognitionand cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183:787–791. https://doi.org/10.4049/jimmunol.0901363 Vanaja SK, Russo AJ, Behl B, Banerjee I, Yankova M, Deshmukh SD, Rathinam VAK (2016) Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation. Cell 165:1106–1119. https://doi.org/10.1016/j.cell.2016.04.015 Deng M, Tang Y, Li W, Wang X, Zhang R, Zhang X, Zhao X, Liu J, Tang C, Liu Z, Huang Y, Peng H, Xiao L, Tang D, Scott MJ, Wang Q, Liu J, Xiao X, Watkins S, Li J, Yang H, Wang H, Chen F, Tracey KJ, Billiar TR, Lu B (2018) The endotoxin delivery protein HMGB1 mediates caspase-11-dependent lethality in sepsis. Immunity 49:740–753.e7. https://doi.org/10.1016/j.immuni.2018.08.016 Netea MG, Nold-Petry CA, Nold MF, Joosten LAB, Opitz B, van der Meer JHM, van de Veerdonk FL, Ferwerda G, Heinhuis B, Devesa I, Funk CJ, Mason RJ, Kullberg BJ, Rubartelli A, van der Meer JWM, Dinarello CA (2009) Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113:2324–2335. https://doi.org/10.1182/blood-2008-03-146720 Gaidt MM, Ebert TS, Chauhan D, Schmidt T, Schmid-Burgk JL, Rapino F, Robertson AAB, Cooper MA, Graf T, Hornung V (2016) Human monocytes engage an alternative inflammasome pathway. Immunity 44:833–846. https://doi.org/10.1016/j.immuni.2016.01.012 Zewinger S, Reiser J, Jankowski V, Alansary D, Hahm E, Triem S, Klug M, Schunk SJ, Schmit D, Kramann R, Körbel C, Ampofo E, Laschke MW, Selejan S-R, Paschen A, Herter T, Schuster S, Silbernagel G, Sester M, Sester U, Aßmann G, Bals R, Kostner G, Jahnen-Dechent W, Menger MD, Rohrer L, März W, Böhm M, Jankowski J, Kopf M, Latz E, Niemeyer BA, Fliser D, Laufs U, Speer T (2020) Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation. Nat Immunol 21:30–41. https://doi.org/10.1038/s41590-019-0548-1 Pasare C, Medzhitov R (2005) Control of B-cell responses by Toll-like receptors. Nature 438:364–368. https://doi.org/10.1038/nature04267 Kaisho T, Takeuchi O, Kawai T, Hoshino K (1950) Akira S (2001) Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol 166:5688–5694. https://doi.org/10.4049/jimmunol.166.9.5688 Hoebe K, Janssen EM, Kim SO, Alexopoulou L, Flavell RA, Han J, Beutler B (2003) Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 4:1223–1229. https://doi.org/10.1038/ni1010 Shen H, Tesar BM, Walker WE (1950) Goldstein DR (2008) dual signaling of MyD88 and TRIF are critical for maximal TLR4-induced dendritic cell maturation. J Immunol 181:1849–1858 Turley SJ, Inaba K, Garrett WS, Ebersold M, Unternaehrer J, Steinman RM, Mellman I (2000) Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288:522–527. https://doi.org/10.1126/science.288.5465.522 Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I (2003) Activation of lysosomal function during dendritic cell maturation. Science 299:1400–1403. https://doi.org/10.1126/science.1080106 Nair-Gupta P, Baccarini A, Tung N, Seyffer F, Florey O, Huang Y, Banerjee M, Overholtzer M, Roche PA, Tampé R, Brown BD, Amsen D, Whiteheart SW, Blander JM (2014) TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation. Cell 158:506–521. https://doi.org/10.1016/j.cell.2014.04.054 Zanoni I, Ostuni R, Capuano G, Collini M, Caccia M, Ronchi AE, Rocchetti M, Mingozzi F, Foti M, Chirico G, Costa B, Zaza A, Ricciardi-Castagnoli P, Granucci F (2009) CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 460:264–268. https://doi.org/10.1038/nature08118 Ling GS, Bennett J, Woollard KJ, Szajna M, Fossati-Jimack L, Taylor PR, Scott D, Franzoso G, Cook HT, Botto M (2014) Integrin CD11b positively regulates TLR4-induced signalling pathways in dendritic cells but not in macrophages. Nat Commun 5:3039. https://doi.org/10.1038/ncomms4039 Terstappen LW, Hollander Z, Meiners H, Loken MR (1990) Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J Leukoc Biol 48:138–148. https://doi.org/10.1002/jlb.48.2.138 Varadaradjalou S, Féger F, Thieblemont N, Hamouda NB, Pleau J-M, Dy M, Arock M (2003) Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 33:899–906. https://doi.org/10.1002/eji.200323830 Brenner SA, Zacheja S, Schäffer M, Feilhauer K, Bischoff SC, Lorentz A (2014) Soluble CD14 is essential for lipopolysaccharide-dependent activation of human intestinal mast cells from macroscopically normal as well as Crohn’s disease tissue. Immunology 143:174–183. https://doi.org/10.1111/imm.12299 Reynolds JM, Martinez GJ, Chung Y, Dong C (2012) Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc Natl Acad Sci 109:13064–13069. https://doi.org/10.1073/pnas.1120585109 Keck S, Müller I, Fejer G, Savic I, Tchaptchet S, Nielsen PJ, Galanos C, Huber M (1950) Freudenberg MA (2011) Absence of TRIF signaling in lipopolysaccharide-stimulated murine mast cells. J Immunol 186:5478–5488. https://doi.org/10.4049/jimmunol.1000458 Ikeda T, Funaba M (2003) Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan. Immunol Lett 88:21–26. https://doi.org/10.1016/s0165-2478(03)00031-2 Dietrich N, Rohde M, Geffers R, Kröger A, Hauser H, Weiss S, Gekara NO (2010) Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. Proc Natl Acad Sci 107:8748–8753. https://doi.org/10.1073/pnas.0912551107 Tamassia N, Moigne VL, Calzetti F, Donini M, Gasperini S, Ear T, Cloutier A, Martinez FO, Fabbri M, Locati M, Mantovani A, McDonald PP, Cassatella MA (2007) The MYD88-independent pathway is not mobilized in human neutrophils stimulated via TLR4. J Immunol 178:7344–7356. https://doi.org/10.4049/jimmunol.178.11.7344 Mitroulis I, Kourtzelis I, Kambas K, Rafail S, Chrysanthopoulou A, Speletas M, Ritis K (2010) Regulation of the autophagic machinery in human neutrophils. Eur J Immunol 40:1461–1472. https://doi.org/10.1002/eji.200940025 El-Benna J, Hurtado-Nedelec M, Marzaioli V, Marie J-C, Gougerot-Pocidalo M-A, Dang PM-C (2016) Priming of the neutrophil respiratory burst: role in host defense and inflammation. Immunol Rev 273:180–193. https://doi.org/10.1111/imr.12447 Chen S, Deng Y, He Q, Chen Y, Wang D, Sun W, He Y, Zou Z, Liang Z, Chen R, Yao L, Tao A (2020) Toll-like receptor 4 deficiency aggravates airway hyperresponsiveness and inflammation by impairing neutrophil apoptosis in a toluene diisocyanate-induced murine asthma model. Allergy Asthma Immunol Res 12:608–625. https://doi.org/10.4168/aair.2020.12.4.608 Smuda C, Wechsler JB, Bryce PJ (2011) TLR-induced activation of neutrophils promotes histamine production via a PI3 kinase dependent mechanism. Immunol Lett 141:102–108. https://doi.org/10.1016/j.imlet.2011.08.002 Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532–1535. https://doi.org/10.1126/science.1092385 Pieterse E, Rother N, Yanginlar C, Hilbrands LB, van der Vlag J (2016) Neutrophils discriminate between lipopolysaccharides of different bacterial sources and selectively release neutrophil extracellular traps. Front Immunol 7:484. https://doi.org/10.3389/fimmu.2016.00484 Khan MA, Farahvash A, Douda DN, Licht J-C, Grasemann H, Sweezey N, Palaniyar N (2017) JNK activation turns on LPS- and Gram-negative bacteria-induced NADPH oxidase-dependent suicidal NETosis. Sci Rep 7:3409. https://doi.org/10.1038/s41598-017-03257-z Rajaiah R, Perkins DJ, Ireland DDC, Vogel SN (2015) CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance. Proc Natl Acad Sci 112:8391–8396. https://doi.org/10.1073/pnas.1424980112 Iijima J, Kobayashi S, Kitazume S, Kizuka Y, Fujinawa R, Korekane H, Shibata T, Saitoh S-I, Akashi-Takamura S, Miyake K, Miyoshi E, Taniguchi N (2017) Core fucose is critical for CD14-dependent Toll-like receptor 4 signaling. Glycobiology 27:1006–1015. https://doi.org/10.1093/glycob/cwx075 Nakayama K, Wakamatsu K, Fujii H, Shinzaki S, Takamatsu S, Kitazume S, Kamada Y, Takehara T, Taniguchi N, Miyoshi E (2019) Core fucose is essential glycosylation for CD14-dependent Toll-like receptor 4 and Toll-like receptor 2 signalling in macrophages. J Biochem (Tokyo) 165:227–237. https://doi.org/10.1093/jb/mvy098 Zanoni I, Tan Y, Di Gioia M, Springstead JR, Kagan JC (2017) By capturing inflammatory lipids released from dying cells, the receptor CD14 induces inflammasome-dependent phagocyte hyperactivation. Immunity 47:697–709.e3. https://doi.org/10.1016/j.immuni.2017.09.010 Płóciennikowska A, Zdioruk MI, Traczyk G, Świątkowska A, Kwiatkowska K (2015) LPS-induced clustering of CD14 triggers generation of PI(4,5)P2. J Cell Sci 128:4096–4111. https://doi.org/10.1242/jcs.173104 Płóciennikowska A, Hromada-Judycka A, Dembińska J, Roszczenko P, Ciesielska A, Kwiatkowska K (2016) Contribution of CD14 and TLR4 to changes of the PI(4,5)P2 level in LPS-stimulated cells. J Leukoc Biol 100:1363–1373. https://doi.org/10.1189/jlb.2VMA1215-577R Voss OH, Murakami Y, Pena MY, Lee H-N, Tian L, Margulies DH, Street JM, Yuen PST, Qi C-F, Krzewski K, Coligan JE (2016) Lipopolysaccharide-induced CD300b receptor binding to Toll-like receptor 4 alters signaling to drive cytokine responses that enhance septic shock. Immunity 44:1365–1378. https://doi.org/10.1016/j.immuni.2016.05.005 Chiang C-Y, Veckman V, Limmer K, David M (2012) Phospholipase Cγ-2 and intracellular calcium are required for lipopolysaccharide-induced Toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation. J Biol Chem 287:3704–3709. https://doi.org/10.1074/jbc.C111.328559 Schappe MS, Szteyn K, Stremska ME, Mendu SK, Downs TK, Seegren PV, Mahoney MA, Dixit S, Krupa JK, Stipes EJ, Rogers JS, Adamson SE, Leitinger N, Desai BN (2018) Chanzyme TRPM7 mediates the Ca2+ influx essential for lipopolysaccharide-induced Toll-like receptor 4 endocytosis and macrophage activation. Immunity 48:59–74.e5. https://doi.org/10.1016/j.immuni.2017.11.026 Yin H, Zhou H, Kang Y, Zhang X, Duan X, Alnabhan R, Liang S, Scott DA, Lamont RJ, Shang J, Wang H (2016) Syk negatively regulates TLR4-mediated IFNβ and IL-10 production and promotes inflammatory responses in dendritic cells. Biochim Biophys Acta 1860:588–598. https://doi.org/10.1016/j.bbagen.2015.12.012 Park JG, Son Y-J, Yoo BC, Yang WS, Kim JH, Kim J-H, Cho JY (2017) Syk plays a critical role in the expression and activation of IRAK1 in LPS-treated macrophages. Mediators Inflamm. https://doi.org/10.1155/2017/1506248 Murase M, Kawasaki T, Hakozaki R, Sueyoshi T, Putri DDP, Kitai Y, Sato S, Ikawa M (1950) Kawai T (2018) Intravesicular acidification regulates lipopolysaccharide inflammation and tolerance through TLR4 trafficking. J Immunol 200:2798–2808. https://doi.org/10.4049/jimmunol.1701390 Van Acker T, Eyckerman S, Vande Walle L, Gerlo S, Goethals M, Lamkanfi M, Bovijn C, Tavernier J, Peelman F (2014) The small GTPase Arf6 is essential for the Tram/Trif pathway in TLR4 signaling. J Biol Chem 289:1364–1376. https://doi.org/10.1074/jbc.M113.499194 Ghosh M, Subramani J, Rahman MM (1950) Shapiro LH (2015) CD13 restricts TLR4 endocytic signal transduction in inflammation. J Immunol 194:4466–4476. https://doi.org/10.4049/jimmunol.1403133 Wang Y, Yang Y, Liu X, Wang N, Cao H, Lu Y, Zhou H, Zheng J (2012) Inhibition of clathrin/dynamin-dependent internalization interferes with LPS-mediated TRAM-TRIF-dependent signaling pathway. Cell Immunol 274:121–129. https://doi.org/10.1016/j.cellimm.2011.12.007 Ali F, Hossain MS, Sejimo S, Akashi K (2019) Plasmalogens inhibit endocytosis of Toll-like receptor 4 to attenuate the inflammatory signal in microglial cells. Mol Neurobiol 56:3404–3419. https://doi.org/10.1007/s12035-018-1307-2 Li L, Wan T, Wan M, Liu B, Cheng R, Zhang R (2015) The effect of the size of fluorescent dextran on its endocytic pathway. Cell Biol Int 39:531–539. https://doi.org/10.1002/cbin.10424 Thottacherry JJ, Sathe M, Prabhakara C, Mayor S (2019) Spoiled for choice: diverse endocytic pathways function at the cell surface. Annu Rev Cell Dev Biol 35:55–84. https://doi.org/10.1146/annurev-cellbio-100617-062710 Pascual-Lucas M, Fernandez-Lizarbe S, Montesinos J, Guerri C (2014) LPS or ethanol triggers clathrin- and rafts/caveolae-dependent endocytosis of TLR4 in cortical astrocytes. J Neurochem 129:448–462. https://doi.org/10.1111/jnc.12639 Czerkies M, Borzęcka K, Zdioruk MI, Płóciennikowska A, Sobota A, Kwiatkowska K (2013) An interplay between scavenger receptor A and CD14 during activation of J774 cells by high concentrations of LPS. Immunobiology 218:1217–1226. https://doi.org/10.1016/j.imbio.2013.04.005 Józefowski S, Śróttek M (2017) Lipid raft-dependent endocytosis negatively regulates responsiveness of J774 macrophage-like cells to LPS by down regulating the cell surface expression of LPS receptors. Cell Immunol 312:42–50. https://doi.org/10.1016/j.cellimm.2016.11.008 Kitchens RL, Wang P (1950) Munford RS (1998) Bacterial lipopolysaccharide can enter monocytes via two CD14-dependent pathways. J Immunol 161:5534–5545 Poussin C, Foti M, Carpentier JL, Pugin J (1998) CD14-dependent endotoxin internalization via a macropinocytic pathway. J Biol Chem 273:20285–20291. https://doi.org/10.1074/jbc.273.32.20285 Klein DCG, Skjesol A, Kers-Rebel ED, Sherstova T, Sporsheim B, Egeberg KW, Stokke BT, Espevik T, Husebye H (2015) CD14, TLR4 and TRAM Show different trafficking dynamics during LPS stimulation. Traffic 16:677–690. https://doi.org/10.1111/tra.12274 Tatematsu M, Yoshida R, Morioka Y, Ishii N, Funami K, Watanabe A, Saeki K, Seya T (1950) Matsumoto M (2016) Raftlin controls lipopolysaccharide-induced TLR4 internalization and TICAM-1 signaling in a cell type-specific manner. J Immunol 196:3865–3876. https://doi.org/10.4049/jimmunol.1501734 Hung W-S, Ling P, Cheng J-C, Chang S-S, Tseng C-P (2016) Disabled-2 is a negative immune regulator of lipopolysaccharide-stimulated Toll-like receptor 4 internalization and signaling. Sci Rep 6:35343. https://doi.org/10.1038/srep35343 Edwards AD, Diebold SS, Slack EMC, Tomizawa H, Hemmi H, Kaisho T, Akira S, Reis e Sousa C, (2003) Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 33:827–833. https://doi.org/10.1002/eji.200323797 Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, Chen C-JJ, Dunbar PR, Wadley RB, Jeet V, Vulink AJE, Hart DNJ, Radford KJ (2010) Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 207:1247–1260. https://doi.org/10.1084/jem.20092140 Lewis KL, Caton ML, Bogunovic M, Greter M, Grajkowska LT, Ng D, Klinakis A, Charo IF, Jung S, Gommerman JL, Ivanov II, Liu K, Merad M, Reizis B (2011) Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine. Immunity 35:780–791. https://doi.org/10.1016/j.immuni.2011.08.013 Hémont C, Neel A, Heslan M, Braudeau C, Josien R (2013) Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness. J Leukoc Biol 93:599–609. https://doi.org/10.1189/jlb.0912452 Villani A-C, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, Griesbeck M, Butler A, Zheng S, Lazo S, Jardine L, Dixon D, Stephenson E, Nilsson E, Grundberg I, McDonald D, Filby A, Li W, De Jager PL, Rozenblatt-Rosen O, Lane AA, Haniffa M, Regev A, Hacohen N (2017) Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes and progenitors. Science. https://doi.org/10.1126/science.aah4573 Yin X, Yu H, Jin X, Li J, Guo H, Shi Q, Yin Z, Xu Y, Wang X, Liu R, Wang S (1950) Zhang L (2017) Human blood CD1c+ dendritic cells encompass CD5high and CD5low subsets that differ significantly in phenotype, gene expression, and functions. J Immunol 198:1553–1564. https://doi.org/10.4049/jimmunol.1600193 Uronen-Hansson H, Allen J, Osman M, Squires G, Klein N, Callard RE (2004) Toll-like receptor 2 (TLR2) and TLR4 are present inside human dendritic cells, associated with microtubules and the Golgi apparatus but are not detectable on the cell surface: integrity of microtubules is required for interleukin-12 production in response to internalized bacteria. Immunology 111:173–178. https://doi.org/10.1111/j.0019-2805.2003.01803.x Pérez-Rodríguez MJ, Ibarra-Sánchez A, Román-Figueroa A, Pérez-Severiano F, González-Espinosa C (2020) Mutant huntingtin affects toll-like receptor 4 intracellular trafficking and cytokine production in mast cells. J Neuroinflammation 17:95. https://doi.org/10.1186/s12974-020-01758-9 Takahashi K, Shibata T, Akashi-Takamura S, Kiyokawa T, Wakabayashi Y, Tanimura N, Kobayashi T, Matsumoto F, Fukui R, Kouro T, Nagai Y, Takatsu K, Saitoh S, Miyake K (2007) A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. J Exp Med 204:2963–2976. https://doi.org/10.1084/jem.20071132 Yang Y, Liu B, Dai J, Srivastava PK, Zammit DJ, Lefrançois L, Li Z (2007) Heat shock protein gp96 is a master chaperone for Toll-like receptors and is important in the innate function of macrophages. Immunity 26:215–226. https://doi.org/10.1016/j.immuni.2006.12.005 Visintin A, Halmen KA, Khan N, Monks BG, Golenbock DT, Lien E (2006) MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4). J Leukoc Biol 80:1584–1592. https://doi.org/10.1189/jlb.0606388 Tsukamoto H, Ihara H, Ito R, Ukai I, Suzuki N, Kimoto M, Tomioka Y, Ikeda Y (2013) MD-2-dependent human Toll-like receptor 4 monoclonal antibodies detect extracellular association of Toll-like receptor 4 with extrinsic soluble MD-2 on the cell surface. Biochem Biophys Res Commun 440:31–36. https://doi.org/10.1016/j.bbrc.2013.09.004 Wang D, Lou J, Ouyang C, Chen W, Liu Y, Liu X, Cao X, Wang J, Lu L (2010) Ras-related protein Rab10 facilitates TLR4 signaling by promoting replenishment of TLR4 onto the plasma membrane. Proc Natl Acad Sci 107:13806–13811. https://doi.org/10.1073/pnas.1009428107 Akbar MA, Mandraju R, Tracy C, Hu W, Pasare C, Krämer H (2016) ARC syndrome-linked Vps33B protein is required for inflammatory endosomal maturation and signal termination. Immunity 45:267–279. https://doi.org/10.1016/j.immuni.2016.07.010 Palsson-McDermott EM, Doyle SL, McGettrick AF, Hardy M, Husebye H, Banahan K, Gong M, Golenbock D, Espevik T, O’Neill LAJ (2009) TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway. Nat Immunol 10:579–586. https://doi.org/10.1038/ni.1727 Doyle SL, Husebye H, Connolly DJ, Espevik T, O’Neill LAJ, McGettrick AF (2012) The GOLD domain-containing protein TMED7 inhibits TLR4 signalling from the endosome upon LPS stimulation. Nat Commun 3:707. https://doi.org/10.1038/ncomms1706 Westphal A, Cheng W, Yu J, Grassl G, Krautkrämer M, Holst O, Föger N, Lee K-H (2017) Lysosomal trafficking regulator Lyst links membrane trafficking to toll-like receptor-mediated inflammatory responses. J Exp Med 214:227–244. https://doi.org/10.1084/jem.20141461 Wang Y, Chen T, Han C, He D, Liu H, An H, Cai Z, Cao X (2007) Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4. Blood 110:962–971. https://doi.org/10.1182/blood-2007-01-066027 Kinoshita D, Sakurai C, Morita M, Tsunematsu M, Hori N, Hatsuzawa K (2019) Syntaxin 11 regulates the stimulus-dependent transport of Toll-like receptor 4 to the plasma membrane by cooperating with SNAP-23 in macrophages. Mol Biol Cell 30:1085–1097. https://doi.org/10.1091/mbc.E18-10-0653 Granucci F (2018) The family of LPS signal transducers increases: the arrival of chanzymes. Immunity 48:4–6. https://doi.org/10.1016/j.immuni.2017.12.016 Skjesol A, Yurchenko M, Bösl K, Gravastrand C, Nilsen KE, Grøvdal LM, Agliano F, Patane F, Lentini G, Kim H, Teti G, Sharma AK, Kandasamy RK, Sporsheim B, Starheim KK, Golenbock DT, Stenmark H, McCaffrey M, Espevik T, Husebye H (2019) The TLR4 adaptor TRAM controls the phagocytosis of Gram-negative bacteria by interacting with the Rab11-family interacting protein 2. PLOS Pathog 15:e1007684. https://doi.org/10.1371/journal.ppat.1007684 Kobayashi M, Saitoh S, Tanimura N, Takahashi K, Kawasaki K, Nishijima M, Fujimoto Y, Fukase K, Akashi-Takamura S (1950) Miyake K (2006) Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J Immunol 176:6211–6218. https://doi.org/10.4049/jimmunol.176.10.6211 Saitoh S-I (2009) Chaperones and transport proteins regulate TLR4 trafficking and activation. Immunobiology 214:594–600. https://doi.org/10.1016/j.imbio.2008.11.012 Pelka K, Shibata T, Miyake K, Latz E (2016) Nucleic acid-sensing TLRs and autoimmunity: novel insights from structural and cell biology. Immunol Rev 269:60–75. https://doi.org/10.1111/imr.12375 Gangloff M (2012) Different dimerisation mode for TLR4 upon endosomal acidification? Trends Biochem Sci 37:92–98. https://doi.org/10.1016/j.tibs.2011.11.003 Sepulveda FE, Burgess A, Heiligenstein X, Goudin N, Ménager MM, Romao M, Côte M, Mahlaoui N, Fischer A, Raposo G, Ménasché G, de Saint BG (2015) LYST controls the biogenesis of the endosomal compartment required for secretory lysosome function. Traffic 16:191–203. https://doi.org/10.1111/tra.12244 Cullinane AR, Schäffer AA, Huizing M (2013) The BEACH is hot: a LYST of emerging roles for BEACH-domain containing proteins in human disease. Traffic 14:749–766. https://doi.org/10.1111/tra.12069 Banushi B, Forneris F, Straatman-Iwanowska A, Strange A, Lyne A-M, Rogerson C, Burden JJ, Heywood WE, Hanley J, Doykov I, Straatman KR, Smith H, Bem D, Kriston-Vizi J, Ariceta G, Risteli M, Wang C, Ardill RE, Zaniew M, Latka-Grot J, Waddington SN, Howe SJ, Ferraro F, Gjinovci A, Lawrence S, Marsh M, Girolami M, Bozec L, Mills K, Gissen P (2016) Regulation of post-Golgi LH3 trafficking is essential for collagen homeostasis. Nat Commun. https://doi.org/10.1038/ncomms12111 Hunter MR, Hesketh GG, Benedyk TH, Gingras A-C, Graham SC (2018) Proteomic and biochemical comparison of the cellular interaction partners of human VPS33A and VPS33B. J Mol Biol 430:2153–2163. https://doi.org/10.1016/j.jmb.2018.05.019 Aerbajinai W, Lee K, Chin K (1950) Rodgers GP (2013) Glia maturation factor-γ negatively modulates TLR4 signaling by facilitating TLR4 endocytic trafficking in macrophages. J Immunol 190:6093–6103. https://doi.org/10.4049/jimmunol.1203048 Yang M, Chen T, Han C, Li N, Wan T, Cao X (2004) Rab7b, a novel lysosome-associated small GTPase, is involved in monocytic differentiation of human acute promyelocytic leukemia cells. Biochem Biophys Res Commun 318:792–799. https://doi.org/10.1016/j.bbrc.2004.04.115 Progida C, Cogli L, Piro F, De Luca A, Bakke O, Bucci C (2010) Rab7b controls trafficking from endosomes to the TGN. J Cell Sci 123:1480–1491. https://doi.org/10.1242/jcs.051474 Klaver EJ, van der Pouw KTCTM, Laan LC, Kringel H, Cummings RD, Bouma G, Kraal G, van Die I (2015) Trichuris suis soluble products induce Rab7b expression and limit TLR4 responses in human dendritic cells. Genes Immun 16:378–387. https://doi.org/10.1038/gene.2015.18 Qi J, Rong Y, Wang L, Xu J, Zhao K (2019) Rab7b overexpression-ameliorated ischemic brain damage following tMCAO Involves suppression of TLR4 and NF-κB p65. J Mol Neurosci MN 68:163–170. https://doi.org/10.1007/s12031-019-01295-y Rojas R, van Vlijmen T, Mardones GA, Prabhu Y, Rojas AL, Mohammed S, Heck AJR, Raposo G, van der Sluijs P, Bonifacino JS (2008) Regulation of retromer recruitment to endosomes by sequential action of Rab5 and Rab7. J Cell Biol 183:513–526. https://doi.org/10.1083/jcb.200804048 Yin J, Liu X, He Q, Zhou L, Yuan Z, Zhao S (2016) Vps35-dependent recycling of Trem2 regulates microglial function. Traffic 17:1286–1296. https://doi.org/10.1111/tra.12451 Ciesielska A, Sas-Nowosielska H, Kwiatkowska K (2017) Bis(monoacylglycero)phosphate inhibits TLR4-dependent RANTES production in macrophages. Int J Biochem Cell Biol 83:15–26. https://doi.org/10.1016/j.biocel.2016.12.003 Grant BD, Donaldson JG (2009) Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol 10:597–608. https://doi.org/10.1038/nrm2755 Naslavsky N, Caplan S (2018) The enigmatic endosome - sorting the ins and outs of endocytic trafficking. J Cell Sci. https://doi.org/10.1242/jcs.216499 Green EG, Ramm E, Riley NM, Spiro DJ, Goldenring JR, Wessling-Resnick M (1997) Rab11 is associated with transferrin-containing recycling compartments in K562 cells. Biochem Biophys Res Commun 239:612–616. https://doi.org/10.1006/bbrc.1997.7520 Yu B, Hailman E, Wright SD (1997) Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 99:315–324. https://doi.org/10.1172/JCI119160 Fassbender K, Walter S, Kühl S, Landmann R, Ishii K, Bertsch T, Stalder AK, Muehlhauser F, Liu Y, Ulmer AJ, Rivest S, Lentschat A, Gulbins E, Jucker M, Staufenbiel M, Brechtel K, Walter J, Multhaup G, Penke B, Adachi Y, Hartmann T, Beyreuther K (2004) The LPS receptor (CD14) links innate immunity with Alzheimer’s disease. FASEB J 18:203–205. https://doi.org/10.1096/fj.03-0364fje Zanoni I, Tan Y, Di Gioia M, Broggi A, Ruan J, Shi J, Donado CA, Shao F, Wu H, Springstead JR, Kagan JC (2016) An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells. Science 352:1232–1236. https://doi.org/10.1126/science.aaf3036 Prymas K, Świątkowska A, Traczyk G, Ziemlińska E, Dziewulska A, Ciesielska A, Kwiatkowska K (2020) Sphingomyelin synthase activity affects TRIF-dependent signaling of Toll-like receptor 4 in cells stimulated with lipopolysaccharide. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158549. https://doi.org/10.1016/j.bbalip.2019.158549 Gupta GD, Dey G, Swetha MG, Ramalingam B, Shameer K, Thottacherry JJ, Kalappurakkal JM, Howes MT, Chandran R, Das A, Menon S, Parton RG, Sowdhamini R, Thattai M, Mayor S (2014) Population distribution analyses reveal a hierarchy of molecular players underlying parallel endocytic pathways. PLoS ONE 9:e100554. https://doi.org/10.1371/journal.pone.0100554 van der Mark VA, Ghiboub M, Marsman C, Zhao J, van Dijk R, Hiralall JK, Ho-Mok KS, Castricum Z, de Jonge WJ, Oude Elferink RPJ, Paulusma CC (2017) Phospholipid flippases attenuate LPS-induced TLR4 signaling by mediating endocytic retrieval of Toll-like receptor 4. Cell Mol Life Sci 74:715–730. https://doi.org/10.1007/s00018-016-2360-5 Lakshminarayan R, Wunder C, Becken U, Howes MT, Benzing C, Arumugam S, Sales S, Ariotti N, Chambon V, Lamaze C, Loew D, Shevchenko A, Gaus K, Parton RG, Johannes L (2014) Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers. Nat Cell Biol 16:595–606. https://doi.org/10.1038/ncb2970 Kalia M, Kumari S, Chadda R, Hill MM, Parton RG, Mayor S (2006) Arf6-independent GPI-anchored protein-enriched early endosomal compartments fuse with sorting endosomes via a Rab5/phosphatidylinositol-3′-kinase–dependent machinery. Mol Biol Cell 17:3689–3704. https://doi.org/10.1091/mbc.E05-10-0980 Guerville M, Boudry G (2016) Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation. Am J Physiol Gastrointest Liver Physiol 311:G1–G15. https://doi.org/10.1152/ajpgi.00098.2016 Weinrauch Y, Katz SS, Munford RS, Elsbach P, Weiss J (1999) Deacylation of purified lipopolysaccharides by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate. Infect Immun 67:3376–3382 Minasyan H (2019) Sepsis: mechanisms of bacterial injury to the patient. Scand J Trauma Resusc Emerg Med 27:19. https://doi.org/10.1186/s13049-019-0596-4 Levels JH, Abraham PR, van den Ende A, van Deventer SJ (2001) Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun 69:2821–2828. https://doi.org/10.1128/IAI.69.5.2821-2828.2001 Vreugdenhil ACE, Rousseau CH, Hartung T, Greve JWM (1950) van ’t Veer C, Buurman WA (2003) Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol 170:1399–1405. https://doi.org/10.4049/jimmunol.170.3.1399 Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C (2004) CD14 Is an Acute-Phase Protein. J Immunol 172:4470–4479. https://doi.org/10.4049/jimmunol.172.7.4470 Memar MY, Baghi HB (2019) Presepsin: a promising biomarker for the detection of bacterial infections. biomed pharmacother biomedecine pharmacother 111:649–656. https://doi.org/10.1016/j.biopha.2018.12.124 Thompson PA, Tobias PS, Viriyakosol S, Kirkland TN, Kitchens RL (2003) Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J Biol Chem 278:28367–28371. https://doi.org/10.1074/jbc.M302921200 Kitchens RL, Thompson PA, Viriyakosol S, O’Keefe GE, Munford RS (2001) Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J Clin Invest 108:485–493. https://doi.org/10.1172/JCI13139 Shao B, Munford RS, Kitchens R, Varley AW (2012) Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes. Innate Immun 18:825–833. https://doi.org/10.1177/1753425912442431 Topchiy E, Cirstea M, Kong HJ, Boyd JH, Wang Y, Russell JA, Walley KR (2016) Lipopolysaccharide is cleared from the circulation by hepatocytes via the low density lipoprotein receptor. PLoS ONE 11:e0155030. https://doi.org/10.1371/journal.pone.0155030 Suzuki K, Murakami T, Hu Z, Tamura H, Kuwahara-Arai K, Iba T (1950) Nagaoka I (2016) Human host defense cathelicidin peptide LL-37 enhances the lipopolysaccharide uptake by liver sinusoidal endothelial cells without cell activation. J Immunol 196:1338–1347. https://doi.org/10.4049/jimmunol.1403203 Yao Z, Mates JM, Cheplowitz AM, Hammer LP, Maiseyeu A, Phillips GS, Wewers MD, Rajaram MVS, Robinson JM, Anderson CL (1950) Ganesan LP (2016) Blood-borne lipopolysaccharide is rapidly eliminated by liver sinusoidal endothelial cells via high-density lipoprotein. J Immunol 197:2390–2399. https://doi.org/10.4049/jimmunol.1600702 Yokoyama S, Cai Y, Murata M, Tomita T, Yoneda M, Xu L, Pilon AL, Cachau RE, Kimura S (2018) A novel pathway of LPS uptake through syndecan-1 leading to pyroptotic cell death. eLife 7.https://doi.org/10.7554/eLife.37854 Dunzendorfer S, Lee H-K, Soldau K, Tobias PS (2004) TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J Immunol 173:1166–1170. https://doi.org/10.4049/jimmunol.173.2.1166 Scott MJ, Billiar TR (2008) Beta2-integrin-induced p38 MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of lipopolysaccharide by hepatocytes. J Biol Chem 283:29433–29446. https://doi.org/10.1074/jbc.M803905200 Lu M (1950) Munford RS (2011) The transport and inactivation kinetics of bacterial lipopolysaccharide influence its immunological potency in vivo. J Immunol 187:3314–3320. https://doi.org/10.4049/jimmunol.1004087 Qian G, Jiang W, Zou B, Feng J, Cheng X, Gu J, Chu T, Niu C, He R, Chu Y, Lu M (2018) LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma. J Exp Med 215:2397–2412. https://doi.org/10.1084/jem.20172225 Zou B, Jiang W, Han H, Li J, Mao W, Tang Z, Yang Q, Qian G, Qian J, Zeng W, Gu J, Chu T, Zhu N, Zhang W, Yan D, He R, Chu Y, Lu M (2017) Acyloxyacyl hydrolase promotes the resolution of lipopolysaccharide-induced acute lung injury. PLoS Pathog 13:e1006436. https://doi.org/10.1371/journal.ppat.1006436 Gorelik A, Illes K, Nagar B (2018) Crystal structure of the mammalian lipopolysaccharide detoxifier. Proc Natl Acad Sci 115:E896–E905. https://doi.org/10.1073/pnas.1719834115 Kaliannan K, Hamarneh SR, Economopoulos KP, Nasrin Alam S, Moaven O, Patel P, Malo NS, Ray M, Abtahi SM, Muhammad N, Raychowdhury A, Teshager A, Mohamed MMR, Moss AK, Ahmed R, Hakimian S, Narisawa S, Millán JL, Hohmann E, Warren HS, Bhan AK, Malo MS, Hodin RA (2013) Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci 110:7003–7008. https://doi.org/10.1073/pnas.1220180110 Fink MP (2014) Animal models of sepsis. Virulence 5:143–153. https://doi.org/10.4161/viru.26083 Shao B, Lu M, Katz SC, Varley AW, Hardwick J, Rogers TE, Ojogun N, Rockey DC, Dematteo RP, Munford RS (2007) A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen. J Biol Chem 282:13726–13735. https://doi.org/10.1074/jbc.M609462200 Parker H, Bigger BW (2019) The role of innate immunity in mucopolysaccharide diseases. J Neurochem 148:639–651. https://doi.org/10.1111/jnc.14632 Simonaro CM (2016) Lysosomes, lysosomal storage diseases, and inflammation.J Inborn Errors Metab Screen 4:1–8. https://doi.org/10.1177/2326409816650465 Simonaro CM, D’Angelo M, He X, Eliyahu E, Shtraizent N, Haskins ME, Schuchman EH (2008) Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases. Am J Pathol 172:112–122. https://doi.org/10.2353/ajpath.2008.070564 Simonaro CM, Ge Y, Eliyahu E, He X, Jepsen KJ, Schuchman EH (2010) Involvement of the Toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses. Proc Natl Acad Sci 107:222–227. https://doi.org/10.1073/pnas.0912937107 Ausseil J, Desmaris N, Bigou S, Attali R, Corbineau S, Vitry S, Parent M, Cheillan D, Fuller M, Maire I, Vanier M-T, Heard J-M (2008) Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice. PLoS ONE 3:e2296. https://doi.org/10.1371/journal.pone.0002296 Suzuki M, Sugimoto Y, Ohsaki Y, Ueno M, Kato S, Kitamura Y, Hosokawa H, Davies JP, Ioannou YA, Vanier MT, Ohno K, Ninomiya H (2007) Endosomal accumulation of Toll-like receptor 4 causes constitutive secretion of cytokines and activation of signal transducers and activators of transcription in Niemann-Pick disease type C (NPC) fibroblasts: a potential basis for glial cell activation in the NPC brain. J Neurosci 27:1879–1891. https://doi.org/10.1523/JNEUROSCI.5282-06.2007 Hauber H-P, Tulic MK, Tsicopoulos A, Wallaert B, Olivenstein R, Daigneault P, Hamid Q (2005) Toll-like receptors 4 and 2 expression in the bronchial mucosa of patients with cystic fibrosis. Can Respir J 12:13–18. https://doi.org/10.1155/2005/648984 Bruscia EM, Zhang P-X, Ferreira E, Caputo C, Emerson JW, Tuck D, Krause DS, Egan ME (2009) Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator−/− mice. Am J Respir Cell Mol Biol 40:295–304. https://doi.org/10.1165/rcmb.2008-0170OC Muir A, Soong G, Sokol S, Reddy B, Gomez MI, Van Heeckeren A, Prince A (2004) Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 30:777–783. https://doi.org/10.1165/rcmb.2003-0329OC Kelly C, Canning P, Buchanan PJ, Williams MT, Brown V, Gruenert DC, Elborn JS, Ennis M, Schock BC (2013) Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 304:L371–382. https://doi.org/10.1152/ajplung.00372.2011 Bruscia EM, Zhang P-X, Satoh A, Caputo C, Medzhitov R, Shenoy A, Egan ME (1950) Krause DS (2011) Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis. J Immunol 186:6990–6998. https://doi.org/10.4049/jimmunol.1100396 Seo SH, Hwang SM, Ko JM, Ko JS, Hyun YJ, Cho SI, Park H, Kim SY, Seong M-W, Park SS (2015) Identification of novel mutations in the VPS33B gene involved in arthrogryposis, renal dysfunction, and cholestasis syndrome. Clin Genet 88:80–84. https://doi.org/10.1111/cge.12442 Trotta T, Porro C, Calvello R, Panaro MA (2014) Biological role of Toll-like receptor-4 in the brain. J Neuroimmunol 268:1–12. https://doi.org/10.1016/j.jneuroim.2014.01.014 Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, Bode B, Manietta N, Walter J, Schulz-Schüffer W, Fassbender K (2007) Role of the Toll-Like receptor 4 in neuroinflammation in Alzheimer’s disease. Cell Physiol Biochem 20:947–956. https://doi.org/10.1159/000110455 Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE (2009) CD14 and Toll-like receptors 2 and 4 are required for fibrillar Aβ-stimulated microglial activation. J Neurosci 29:11982–11992. https://doi.org/10.1523/JNEUROSCI.3158-09.2009 Frank S, Copanaki E, Burbach GJ, Müller UC, Deller T (2009) Differential regulation of Toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice. Neurosci Lett 453:41–44. https://doi.org/10.1016/j.neulet.2009.01.075 Tang S-C, Lathia JD, Selvaraj PK, Jo D-G, Mughal MR, Cheng A, Siler DA, Markesbery WR, Arumugam TV, Mattson MP (2008) Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp Neurol 213:114–121. https://doi.org/10.1016/j.expneurol.2008.05.014 Casula M, Iyer AM, Spliet WGM, Anink JJ, Steentjes K, Sta M, Troost D, Aronica E (2011) Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue. Neuroscience 179:233–243. https://doi.org/10.1016/j.neuroscience.2011.02.001 Letiembre M, Liu Y, Walter S, Hao W, Pfander T, Wrede A, Schulz-Schaeffer W, Fassbender K (2009) Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurobiol Aging 30:759–768. https://doi.org/10.1016/j.neurobiolaging.2007.08.018 Liu Y, Walter S, Stagi M, Cherny D, Letiembre M, Schulz-Schaeffer W, Heine H, Penke B, Neumann H, Fassbender K (2005) LPS receptor (CD14): a receptor for phagocytosis of Alzheimer’s amyloid peptide. Brain J Neurol 128:1778–1789. https://doi.org/10.1093/brain/awh531 Martin E, Boucher C, Fontaine B, Delarasse C (2017) Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer’s disease models: effects of aging and amyloid pathology. Aging Cell 16:27–38. https://doi.org/10.1111/acel.12522 Reed-Geaghan EG, Reed QW, Cramer PE, Landreth GE (2010) Deletion of CD14 attenuates Alzheimer’s disease pathology by influencing the brain’s inflammatory milieu. J Neurosci 30:15369–15373. https://doi.org/10.1523/JNEUROSCI.2637-10.2010 Wallings RL, Humble SW, Ward ME, Wade-Martins R (2019) Lysosomal dysfunction at the centre of Parkinson’s disease and frontotemporal dementia/amyotrophic lateral sclerosis. Trends Neurosci 42:899–912. https://doi.org/10.1016/j.tins.2019.10.002 Wang C, Telpoukhovskaia MA, Bahr BA, Chen X, Gan L (2018) Endo-lysosomal dysfunction: a converging mechanism in neurodegenerative diseases. Curr Opin Neurobiol 48:52–58. https://doi.org/10.1016/j.conb.2017.09.005 Schmid W, Novacek G, Vogelsang H, Papay P, Primas C, Eser A, Panzer S (2017) Platelets Toll-like receptor-4 in Crohns disease. Eur J Clin Invest 47:109–116. https://doi.org/10.1111/eci.12686 Roviezzo F, Sorrentino R, Terlizzi M, Riemma MA, Iacono VM, Rossi A, Spaziano G, Pinto A, D’Agostino B, Cirino G (2017) Toll-Like Receptor 4 is essential for the expression of sphingosine-1-phosphate-dependent asthma-like disease in mice. Front Immunol 8:1336. https://doi.org/10.3389/fimmu.2017.01336 Alibashe-Ahmed M, Brioudes E, Reith W, Bosco D, Berney T (2019) Toll-like receptor 4 inhibition prevents autoimmune diabetes in NOD mice. Sci Rep 9:19350. https://doi.org/10.1038/s41598-019-55521-z Watanabe S, Kumazawa Y, Inoue J (2013) Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD14. PLoS ONE 8:e60078. https://doi.org/10.1371/journal.pone.0060078